BTIG raised the firm’s price target on Intuitive Surgical (ISRG) to $616 from $589 and keeps a Buy rating on the shares. Analysis of the Dv5 launch suggests it accounts for roughly 25.3% of Street-modeled revenue growth in FY26 and 34.5% in FY27, the analyst tells investors in a research note. While this may appear low given the launch’s strategic importance, a deeper look at its impact on both System and Instruments & Accessories revenue provides a fuller view of its contribution to overall growth, BTIG says.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target raised to $686 from $635 at Barclays
- Intuitive Surgical price target raised to $580 from $540 at Evercore ISI
- U.S. Chess Champion Is Bullish on these 3 Stocks
- Intuitive Surgical Restructures Digital and AI Leadership Role
- Intuitive Surgical price target raised to $650 from $620 at Truist